Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections;Invazif enfeksiyonlara neden olan gsbl pozitif enterobacteriaceae izolatlarinda karbapenem direnci

Mikrobiyoloji Bulteni

Volumn 48, Issue 1, 2014, Pages 59-69

  Köseoǧlu Eser, Ozgen ^a   Altun Uludagc, Hatice ^a,b   Ergin, Alper ^a   Boral, Bariş ^a   Şener, Burçin ^a   Ḩascelik, G̈u̧lsen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b TURGUT OZAL UNIVERSITY   (Turkey)

Author keywords

Carbapenem resistance; Carbapenemase; Enterobacteriaceae; ESBL

Indexed keywords

BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; DISK DIFFUSION; DRUG EFFECT; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; TURKEY (REPUBLIC);

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; DISK DIFFUSION ANTIMICROBIAL TESTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; TURKEY;

EID: 84897609295     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gu B, Tong M, Zhao W, et al. Prevalence and characterization of class I integrans among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China. J Clin Microbiol 2007; 45(1): 241-3. (Pubitemid 46106436)
2. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-produdng Enterobacteriaceae. Emerg Infect Dis 2011; 17(10): 1791-8.
3. Miriagou V, Cornaglia G, Edelstein M, et al. Acquired carbapenemases in gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 2010; 16(2): 112-22.
4. nd Informational Supplement. CLSI Document M100-S19, 2009. CLSI, Wayne, PA.
5. nd Informational Supplement. CLSI Document M100-S22, 2012. CLSI, Wayne, PA.
6. Tsakris A, Poulou A, Pournaras S, et al. A simple phenotypic method for the differentiation of metallo-betalactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. Antimicrob Chemother 2010; 65(8): 1664-71.
7. Song W, Bae IK, Lee YN, Lee CH, Lee SH, Jeong SH. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coll. J Clin Microbiol 2007; 45(4): 1180-4. (Pubitemid 46626482)
8. Costa D, Poeta P, Saenz Y, et al. Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets. Vet Microbiol 2008; 127(1 -2): 97-105.
9. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40(6): 2153-62. (Pubitemid 34596400)
10. Kaiser DM, Castanheira M, Jones RN, Tenover F, Lynfield R. Trends in Klebsiella pneumoniae carbapenemasepositive K.pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program. Dlagn Microbiol Infect Dis 2013; 76(3): 356-60.
11. Lebleblcioglu H, Cakir N, Celen M, Kurt H, Baris H, Laeuffer J; Turkish COMPACT Study Group. Comparative activity of carbapenem testing (the COMPACT study) in Turkey. BMC Infect Dis 2012; 12: 42.
12. Valenza G, Seifert H, Decker-Burgard S, Laeuffer J, Morrissey I, Mutters R. Comparative activity of carbapenem testing (COMPACT) study in Germany. Int J Antimicrob Agents 2012; 39(3): 255-8.
13. Kiratisin P, Chongthaleong A, Tan TY, et al. Comparative in vitro activity of carbapenems against major gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study. Int J Antimicrob Agents 2012; 39(4): 311-6.
14. Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev 2009; 22(1): 161-82.
15. Baykal A, Çöplü N, Şimşek H, Esen B, Gür D. Kan izolati E.coli ve K.pneumoniae suşlarinda genlşlemiş-spektrumlu beta-laktamaz, KPC-tip karbapenemaz ve plazmid aracili AmpC beta-laktamaz varliǧinin arascedil;tirilmasi. Mikrobiyol Bul 2012; 46(2): 159-69.
16. Birgy A, Bidet P, Genel N, et al. Phenotypic screening of carbapenemases and associated beta-lactamase in carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 2012; 50(4): 1295-302.
17. Girlich D, Poirel L, Nordmann P. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol 2012; 50(2): 477-9.
18. Gomez E, Urban C, Mariano N, et al. Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital. Microb Drug Resist 2011; 17(2): 251-7.
19. Doumith M, Ellington MJ, Livermore DM, Woodford N. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 2009; 63(4): 659-67.
20. Baroud M, Dandache I, Araj GF, et al. Underlying mechanisms of carbapenem resistance in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coll isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases. Int J Antimicrob Agents 2013; 41 (1) : 75-9.
21. Poirel L, Heritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48(1): 15-22. (Pubitemid 38040171)
22. Patel A, Bonomo RA. Stormy waters ahead: global emergence of carbapenemases. Front Microbiol 2013; 4: 48.
23. Canton R, Akova M, Carmelli Y, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012; 18(5): 413-31.
24. Gupta V, Bansal N, Singla N, Chander J. Occurence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center. J Microbiol Immunol Infect 2013; 46(2): 104-8.
25. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in klebsiella pneumoniae and other enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012; 25(4): 682-707.